Physician profile
William E Brown
NPI 1275590416
$8,452.31
in general payments reported to CMS, 2019-2025
32 companies · $488 in 2025
The $488 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $226 · 2023: $156 · 2024: $6,772 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $1,415.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,270.40 | 2024 | |
| Astellas Pharma US INC | $192.73 | 2020-2025 | Veozah |
| Novo Nordisk INC | $173.59 | 2019-2025 | Wegovy |
| Abbvie INC. | $166.67 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Coopersurgical, INC. | $142.45 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $122.51 | 2019-2025 | Slynd |
| Organon LLC | $113.27 | 2023-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $112.48 | 2019-2025 | |
| Therapeuticsmd, INC. | $104.51 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $100.56 | 2019-2020 | |
| Lilly USA, LLC | $90.98 | 2024-2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $84.99 | 2019-2020 | |
| Pfizer INC. | $84.95 | 2019-2025 | |
| Amgen INC. | $78.16 | 2019-2024 | Evenity, Prolia |
| Boston Scientific Corporation | $76.36 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $73.01 | 2020-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Daiichi Sankyo INC. | $64.26 | 2019 | |
| Mayne Pharma Commercial LLC | $58.75 | 2023-2025 | |
| Amag Pharmaceuticals, INC. | $41.67 | 2019 | |
| Meditrina | $39.09 | 2023-2024 | |
| Sanofi Pasteur INC. | $32.26 | 2025 | |
| Vivus LLC | $29.93 | 2019-2020 | |
| Exact Sciences Corporation | $27.95 | 2024 | Cologuard Collection Kit |
| Allergan, INC. | $25.26 | 2019-2020 | |
| Gynesonics, INC. | $24.72 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Lupin INC. | $22.17 | 2019 | |
| Mimedx Group, INC. | $20.67 | 2025 | |
| Minerva Surgical, INC | $20.67 | 2025 | |
| Eisai INC. | $15.93 | 2019 | |
| Coloplast Corp | $14.20 | 2019 | |
| Avion Pharmaceuticals | $14.09 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.